Rehabilitation of communication in people with traumatic brain injury: a systematic review of types of intervention and therapeutic ingredients (Rehabilitación de la comunicación en personas con traumatismo encefalocraneal: una revisión sistemática de tipos de intervención e ingredientes terapéuticos). Issue 1 (2nd January 2022)

• Record Type: Journal Article
• Authors: Tobar-Fredes, Rodrigo; Salas, Christian
• Is Part Of: Estudios de psicologia. Volume 43:Issue 1(2022)
• Page Start: 88
• Page End: 131
• Publication Date: 2022-01-02
• Subjects: traumatic brain injury -- communication disorder -- cognitive-communication disorder -- neuropsychological rehabilitation; traumatismo encefalocraneal -- trastorno de la comunicación -- trastorno cognitivo-comunicativo -- rehabilitación neuropsicológica; Psychology -- Periodicals; 150.5
• DOI: 10.1080/02109395.2021.2009292
• Languages: English
• ISSNs: 0210-9395

Abstract

ABSTRACT: Background: the treatment of cognitive-communication disorder (CCD) has proven an adequate approach to the social well-being of people with traumatic brain injury (TBI). Objective: describe the types of treatment and therapeutic ingredients — and their effectiveness — available for the direct treatment of CCD in people with TBI. Method: a systematic review following PRISMA guidelines was carried out. The effectiveness of each type of treatment and the therapeutic ingredients available were assessed. Results: 22 articles met inclusion criteria. Three interventions (rehabilitation of emotional perception-regulation and social cognitive skills, pragmatic skills and conversation/interaction) achieved recommendation A. All therapeutic ingredients (education, functional goals, progressive approach, modelling, skills practice, feedback, simulation, practice with peers, emotional adjustment) had sufficient evidence for recommendation level A. Conclusions: direct communication treatment is an effective approach for people with brain injury and should be included as a practice standard. The need to develop a generic model to treat CCD that combines therapeutic ingredients from diverse interventions is discussed.